BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...
Because 13% survival is not enough, PanCAN has set a bold goal: Drive the five-year survival rate to 20% by 2030. We will do ...
Scientists say they have worked out a machine learning method with the ability to provide close to precise survival estimates of patients afflicted with prostate adenocarcinoma, which is by far the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback